EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals Revenue

EyePoint Pharmaceuticals had revenue of $966.00K in the quarter ending September 30, 2025, a decrease of -90.82%. This brings the company's revenue in the last twelve months to $42.34M, down -7.38% year-over-year. In the year 2024, EyePoint Pharmaceuticals had annual revenue of $43.27M, down -5.97%.

• Revenue (ttm): $42.34M
• Revenue Growth: -7.38%
• P/S Ratio: 18.77
• Revenue / Employee: $256,600
• Employees: 165
• Market Cap: 958.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	43.27M	-2.75M	-5.97%
Dec 31, 2023	46.02M	4.61M	11.14%
Dec 31, 2022	41.40M	4.47M	12.09%
Dec 31, 2021	36.94M	2.50M	7.27%
Dec 31, 2020	34.44M	14.07M	69.10%